PeptideDB

JAMM protein inhibitor 2 848249-35-4

JAMM protein inhibitor 2 848249-35-4

CAS No.: 848249-35-4

JAMM protein inhibitor 2 (compound 180) is a potent JAMM protease inhibitor (antagonist) with IC50s of 10 μM, 46 μM an
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

JAMM protein inhibitor 2 (compound 180) is a potent JAMM protease inhibitor (antagonist) with IC50s of 10 μM, 46 μM and 89 μM for thrombin, Rpn11 and MMP2 respectively. JAMM protein inhibitor 2 may be utilized in anti-cancer research.

Physicochemical Properties


Molecular Formula C21H26N2O2
Molecular Weight 338.443345546722
Exact Mass 338.199
CAS # 848249-35-4
PubChem CID 4853066
Appearance Light yellow to brown solid powder
LogP 4.6
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 6
Heavy Atom Count 25
Complexity 422
Defined Atom Stereocenter Count 0
SMILES

O=C(COC1C(CC)=CC=CC=1)NC1C(C)=CC(N2CCCC2)=CC=1

InChi Key BWVQJXWDZCDJJJ-UHFFFAOYSA-N
InChi Code

InChI=1S/C21H26N2O2/c1-3-17-8-4-5-9-20(17)25-15-21(24)22-19-11-10-18(14-16(19)2)23-12-6-7-13-23/h4-5,8-11,14H,3,6-7,12-13,15H2,1-2H3,(H,22,24)
Chemical Name

2-(2-ethylphenoxy)-N-(2-methyl-4-pyrrolidin-1-ylphenyl)acetamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Methods and compositions for jamm protease inhibition. WO2013123071A1 (compound 180).


Solubility Data


Solubility (In Vitro) DMSO : ~14.71 mg/mL (~43.46 mM)
Solubility (In Vivo) Solubility in Formulation 1: 1.47 mg/mL (4.34 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.7 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: 1.47 mg/mL (4.34 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.7 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 1.47 mg/mL (4.34 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.7 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.9547 mL 14.7737 mL 29.5473 mL
5 mM 0.5909 mL 2.9547 mL 5.9095 mL
10 mM 0.2955 mL 1.4774 mL 2.9547 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.